Friday, August 19, 2005


New Patents Strengthen EntreMed Position in Cancer and
PR Newswire (press release), NY - Aug 17, 2005 (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammation, today announced the issuance of

0 Comments:

Post a Comment

<< Home